Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3183695731;95732;95733 chr2:178545604;178545603;178545602chr2:179410331;179410330;179410329
N2AB3019590808;90809;90810 chr2:178545604;178545603;178545602chr2:179410331;179410330;179410329
N2A2926888027;88028;88029 chr2:178545604;178545603;178545602chr2:179410331;179410330;179410329
N2B2277168536;68537;68538 chr2:178545604;178545603;178545602chr2:179410331;179410330;179410329
Novex-12289668911;68912;68913 chr2:178545604;178545603;178545602chr2:179410331;179410330;179410329
Novex-22296369112;69113;69114 chr2:178545604;178545603;178545602chr2:179410331;179410330;179410329
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGC
  • RefSeq wild type template codon: CCG
  • Domain: Fn3-120
  • Domain position: 30
  • Structural Position: 32
  • Q(SASA): 0.5407
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 1.0 D 0.709 0.652 0.451599300725 gnomAD-4.0.0 1.59139E-06 None None None None I None 0 0 None 0 0 None 0 0 0 1.43283E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.7798 likely_pathogenic 0.7934 pathogenic -0.185 Destabilizing 1.0 D 0.63 neutral N 0.515040168 None None I
G/C 0.7999 likely_pathogenic 0.8012 pathogenic -0.872 Destabilizing 1.0 D 0.787 deleterious D 0.540198769 None None I
G/D 0.8325 likely_pathogenic 0.8331 pathogenic -0.557 Destabilizing 1.0 D 0.709 prob.delet. D 0.53079102 None None I
G/E 0.8614 likely_pathogenic 0.871 pathogenic -0.716 Destabilizing 1.0 D 0.795 deleterious None None None None I
G/F 0.968 likely_pathogenic 0.9726 pathogenic -0.991 Destabilizing 1.0 D 0.781 deleterious None None None None I
G/H 0.9274 likely_pathogenic 0.9244 pathogenic -0.279 Destabilizing 1.0 D 0.774 deleterious None None None None I
G/I 0.9615 likely_pathogenic 0.9746 pathogenic -0.461 Destabilizing 1.0 D 0.795 deleterious None None None None I
G/K 0.9058 likely_pathogenic 0.9048 pathogenic -0.516 Destabilizing 1.0 D 0.795 deleterious None None None None I
G/L 0.9419 likely_pathogenic 0.9516 pathogenic -0.461 Destabilizing 1.0 D 0.806 deleterious None None None None I
G/M 0.9498 likely_pathogenic 0.9583 pathogenic -0.533 Destabilizing 1.0 D 0.783 deleterious None None None None I
G/N 0.7838 likely_pathogenic 0.7895 pathogenic -0.235 Destabilizing 1.0 D 0.705 prob.neutral None None None None I
G/P 0.9952 likely_pathogenic 0.997 pathogenic -0.345 Destabilizing 1.0 D 0.798 deleterious None None None None I
G/Q 0.84 likely_pathogenic 0.8389 pathogenic -0.512 Destabilizing 1.0 D 0.801 deleterious None None None None I
G/R 0.8379 likely_pathogenic 0.8371 pathogenic -0.11 Destabilizing 1.0 D 0.799 deleterious D 0.525448649 None None I
G/S 0.5171 ambiguous 0.5374 ambiguous -0.369 Destabilizing 1.0 D 0.714 prob.delet. N 0.49303512 None None I
G/T 0.8818 likely_pathogenic 0.9099 pathogenic -0.467 Destabilizing 1.0 D 0.795 deleterious None None None None I
G/V 0.9414 likely_pathogenic 0.9583 pathogenic -0.345 Destabilizing 1.0 D 0.793 deleterious D 0.557289066 None None I
G/W 0.9316 likely_pathogenic 0.9445 pathogenic -1.085 Destabilizing 1.0 D 0.777 deleterious None None None None I
G/Y 0.9385 likely_pathogenic 0.9422 pathogenic -0.766 Destabilizing 1.0 D 0.775 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.